Skip to main content

Table 1 Baseline characteristics and echocardiographic data

From: Left ventricular remodeling after acute myocardial infarction: the influence of viability and revascularization - an echocardiographic substudy of the VIAMI-trial

  Viable Non-viable
  Revascularized Medical   
Characteristic Group 1 (n = 94) Group 2 (n = 71) Group 3 (n = 59) P value*
Male 83% 77% 69% 0.61
Age (years) 61 60 63 0.18
Clinical history
Angina 43% 41% 56% <0.001
Myocardial infarction 7% 3% 12% 0.056
Percutaneous coronary intervention 1% 3% 12% 0.013
Coronary artery bypass graft 0% 0% 0% -
In-hospital
Anterior infarction 29% 31% 46% 0.28
Thrombolysis 56% 49% 47% 0.83
Revascularization 100% 0% 29% <0.001
- Percutaneous coronary intervention 83% 0% 24%  
- Coronary artery bypass graft 17% 0% 5%  
Peak creatine kinase (U/L) 1,617 ± 1,215 1,804 ± 1,321 1,784 ± 1,654 0.66
Peak creatine kinase-MB (U/L) 165 ± 130 204 ± 182 170 ± 149 0.27
Pathological Q waves (n)† 1.70 ± 1.57 1.96 ± 1.48 2.54 ± 2.00 0.01
Persistent ST elevation >1 mm† 20% 34% 54% <0.001
Echocardiography
Viable segments (16 segments model) (n) 3.39 ± 1.43 3.38 ± 1.27 0.37 ± 0.49 0.95‡
LVEDV (ml) 98.5 ± 33.2 88.4 ± 25.2 89.5 ± 33.7 0.07
LVESV (ml) 47.0 ± 25.1 41.9 ± 19.1 42.9 ± 22.5 0.32
LVEF 54.0% 53.3% 53.5% 0.93
WMI 1.54 ± 0.27 1.57 ± 0.26 1.54 ± 0.30 0.78
Follow-up
Follow-up echocardiogram (days) 226 ± 129 178 ± 127 205 ± 134 0.07
Revascularisation (days) 25 ± 66 NA 48 ± 75 0.16§
Risk factors
Diabetes mellitus 10% 11% 8% 0.63
Hypertension 23% 26% 36% 0.11
Hypercholesterolemia 19% 14% 17% 0.91
Current cigarette smoking 46% 35% 64% 0.003
Family history of coronary artery disease 33% 26% 20% 0.25
Medications at admission
Aspirin 14% 11% 12% 0.76
Beta-blocker 11% 12% 17% 0.58
Statins 17% 5% 10% 0.02
ACE-inhibitor 10% 5% 15% 0.11
Angiotensin II antagonist 4% 6% 7% 0.33
Medications at discharge
Aspirin 95% 99% 88% 0.04
Beta-blocker 97% 93% 92% 0.35
Statins 94% 99% 92% 0.18
ACE-inhibitor 54% 58% 68% 0.25
Angiotensin II antagonist 3% 7% 8% 0.35
Clopidogrel 65% 11% 22% <0.001
Diuretics 5% 6% 17% 0.02
  1. *Differences between the groups. †On the electrocardiogram at 48 hours after acute myocardial infarction. §Difference between group 1 and 2. Values are shown as means ± SD unless otherwise indicated. ACE, angiotensin converting enzyme; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; NA, not applicable; WMI, wall motion score index.
Back to article page

Trials

ISSN: 1745-6215